GoldBamboo.com - Knowledge is strong medicine
  

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) - Article


  Not Signed In - Sign In / Register






Biopsychosocial model


Clinical Trial: Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

This study is not yet open for patient recruitment.
Verified by Department of Veterans Affairs August 2005

Sponsors and Collaborators: Department of Veterans Affairs
NIMH UCLA-RAND Center for Research on Quality in Managed Care
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00137280

Purpose

Schizophrenia is a common, disabling illness that has a very high cost to society. In fiscal year 2000, the VA provided care to over 102,000 people with schizophrenia, and 16% of the VA’s health care budget was spent on care for people with psychotic disorders. Effective care for schizophrenia requires evaluating a patient’s needs, and then selecting and ensuring delivery of appropriate treatments from a number of domains. Unfortunately, a large proportion of patients do not receive appropriate care and outcomes in usual practices are much worse than in state-of-the-art care. Common problems in care include inadequate clinical assessment, poor communication among the treatment team, lack of caregiver involvement, and failure to deliver care assertively. Too often, treatments are not matched well with patients’ needs.
Condition Intervention
Schizophrenic Disorder
Chronic Illness
Schizoaffective Disorder
Weight Gain
Psychotic Disorder
 Procedure: Collaborative Chronic Illness Care Model

MedlinePlus related topics:  Mental Health;   Schizophrenia

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study

Official Title: Implementing Effective, Collaborative Care for Schizophrenia

Further Study Details: 
Primary Outcomes: At 9 months, evaluate the effect of care model implementation on provider competencies, treatment appropriateness, patient outcomes and service utilization
Secondary Outcomes: Evaluate processes of and variations in care model implementation and effectiveness to strengthen the intervention and to assess acceptability, how strategies affect implementation and the impact of individual components on treatment appropriateness
Expected Total Enrollment:  1040

Study start: January 2006;  Expected completion: December 2008
Last follow-up: June 2008

Background:

Schizophrenia is a common, disabling illness that has a very high cost to society. In fiscal year 2000, the VA provided care to over 102,000 people with schizophrenia, and 16% of the VA’s health care budget was spent on care for people with psychotic disorders. Effective care for schizophrenia requires evaluating a patient’s needs, and then selecting and ensuring delivery of appropriate treatments from a number of domains. Unfortunately, a large proportion of patients do not receive appropriate care and outcomes in usual practices are much worse than in state-of-the-art care. Common problems in care include inadequate clinical assessment, poor communication among the treatment team, lack of caregiver involvement, and failure to deliver care assertively. Too often, treatments are not matched well with patients’ needs.

Objectives:

The goal of this QUERI Service Directed Project (SDP) is to implement evidence-based treatment for schizophrenia into VA practice. This SDP is a partnership between the Mental Health QUERI and the Mental Illness Research, Education and Clinical Centers (MIRECCs) of VISNs 16, 20 and 22. It builds on the successful VA EQUIP project, which has demonstrated the feasibility and usefulness of a collaborative care model for schizophrenia. The collaborative care model focuses on improving three domains of care for this chronic illness: 1) providing assertive care to severely ill patients; 2) educating and activating caregivers; and 3) ensuring that treatment and rehabilitation respond appropriately to patients’ symptoms, side-effects, and functional impairments. A central component of the care model is routine, brief assessment of key clinical domains. An informatics system provides these psychiatric “vital signs” to clinicians during the patient encounter and facilitates communication among team-members. Reports are generated that identify problems in care for each patient. Clinicians and managers use these reports to enhance access to necessary treatments. Quality coordinators proactively identify and address gaps in care, and ensure collaboration among clinicians, the patient and caregivers.

Methods:

Will use an evidence-based quality improvement strategy to implement collaborative care for schizophrenia at mental health clinics in three VISNs. Study intervention feasibility, acceptability, and impact on outcomes. Perform qualitative analyses examining processes and variation in care model implementation and impact. The project team partners with leadership of the VISNs to adapt methods from EQUIP to local circumstances and to implement collaborative care at mental health clinics. Research includes a controlled trial of the impact of collaborative care, relative to usual care, on treatment quality. Participants include clinic staff and patients with schizophrenia. A process evaluation describes factors related to model acceptability, implementation, and impact. Data sources include interviews with participants, implementation documentation, the project informatics system, and VistA.

Findings:

None at this time.

Status:

Not yet funded.

Impact:

This SDP evaluates implementation of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project creates a platform that other interventions can build upon to improve care, and is designed to inform a national strategy for implementing evidence-based care in schizophrenia.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

Providers (Psychiatrists, Case Managers, Nurses):

Working at one of the participating VA Medical Centers

Patients:

  • At least 18 years old
  • Diagnosis of Schizophrenia, Schizoaffective, or schizophreniform disorder
  • At least 2 treatment visits with a psychiatrist at the clinic during the previous 6 months.

Exclusion Criteria:

None

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00137280


California
      VA Greater Los Angeles Health Care System, Los Angeles,  California,  90073,  United States
Ismelda A Canelo  818-891-7711  Ext. 7500    Ismelda.Canelo@med.va.gov 
Amy N Cohen, PhD  (310) 478-3711  Ext. 40770    ancohen@ucla.edu 
Alexander S. Young, MD MSHS,  Principal Investigator
Amy N. Cohen, PhD,  Sub-Investigator

Study chairs or principal investigators

Alexander S. Young, MD MSHS,  Principal Investigator,  VA Greater Los Angeles Health Care System   

More Information

Study ID Numbers:  MNT 03-213; MH 068639
Last Updated:  August 26, 2005
Record first received:  August 25, 2005
ClinicalTrials.gov Identifier:  NCT00137280
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-30


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Biopsychosocial model.

October 10, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.